| Autor: |
Reses, Hannah E., Segovia, George, Dubendris, Heather, Barbre, Kira, Ananth, Sushmitha, Lape-Newman, Brynn, Wong, Emily, Stillions, Molly, Rowe, Theresa, Mothershed, Elizabeth, Wallender, Erika, Twentyman, Evelyn, Wiegand, Ryan E., Patel, Pragna, Benin, Andrea, Bell, Jeneita M. |
| Předmět: |
|
| Zdroj: |
MMWR: Morbidity & Mortality Weekly Report; 11/21/2024, Vol. 73 Issue 46, p1052-1057, 6p |
| Abstrakt: |
Nursing home residents are at elevated risk for severe complications from respiratory viruses, including SARS-CoV-2, influenza, and respiratory syncytial virus (RSV). Nursing homes are required to report COVID-19 vaccination coverage and can voluntarily report influenza and RSV vaccination coverage among residents to CDC’s National Healthcare Safety Network. The purpose of this study was to assess COVID-19, influenza, and RSV vaccination coverage among nursing home residents early in the 2024–25 respiratory virus season. As of November 10, 2024, 29.7% of nursing home residents had received a 2024–2025 COVID-19 vaccine. Among residents at facilities that elected to report vaccination against influenza (59.4% of facilities) and RSV (51.8% of facilities), 58.4% had received influenza vaccination, and 17.9% had received RSV vaccination. Vaccination coverage varied by U.S. Department of Health and Human Services region, social vulnerability index level, and facility size. Addressing low coverage with COVID-19, influenza, and RSV vaccines is a priority to protect residents who are susceptible to severe outcomes associated with respiratory illnesses. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
